2 results
Approved WMORecruiting
Primary Objective1. To evaluate the efficacy of IMU-838 versus placebo as measured by quantitative magnetic resonance imaging (MRI) analysis for whole brain atrophy in progressive multiple sclerosis (PMS) patients with the Structural Image…
Approved WMORecruiting
The primary objectives of this study are:• To determine the safety and tolerability of EP-104IAR• To determine the pharmacokinetic (PK) profile of EP-104IARA secondary/exploratory objective is:• To evaluate the efficacy of EP-104IAR on eosinophilic…